GLP-1 weight-loss drugs show potential to treat binge eating and obesity, Penn study finds

Posted
People with both obesity and binge eating disorder lost more weight and had higher remission rates of disordered eating when taking semaglutide than people in a placebo group, a new study finds.

Continue reading at PhillyVoice »

Health, Mental Health, Eating Disorders, Philadelphia, Research, Weight Loss Drugs, Studies, University of Pennsylvania, Obesity